Brain Hemorrhages is a pioneering open-access journal published by KEAI PUBLISHING LTD, dedicated to advancing the field of neurology with a specific focus on brain hemorrhages and their clinical implications. Established in 2020, this journal has quickly gained recognition, achieving a 2023 Q3 category ranking in both neurology and clinical neurology, as well as a Q2 ranking in surgery. With an e-ISSN of 2589-238X, it facilitates broad accessibility, allowing researchers and healthcare professionals worldwide to share and access vital findings without barriers. As it converges its publishing efforts toward 2024, Brain Hemorrhages aims to foster interdisciplinary research and clinical insights that can significantly influence treatment outcomes and enhance patient care. The journal stands as a critical resource for those exploring the complexities of brain hemorrhages, making it an essential addition to any academic or professional library within the fields of neurology and surgery.

Turkish Neurosurgery is a distinguished journal published by the TURKISH NEUROSURGICAL SOC, dedicated to advancing the field of neurosurgery and clinical neurology. With an ISSN of 1019-5149 and converging its focus from 1990 to 2024, this regional journal aims to bridge the gap in knowledge dissemination within Turkey and beyond. It holds a notable position in the academic community, categorized in the Q3 quartile for both Neurology (clinical) and Surgery in 2023, illustrating its relevance in these critical fields. Although currently not an open-access publication, it offers insights and research findings that are vital for researchers, practitioners, and students who seek to stay abreast of developments in neurosurgical practices. Located in Ankara, Turkiye, Turkish Neurosurgery provides a platform for sharing rigorous research that enhances clinical outcomes and informs surgical techniques, thus playing a crucial role in elevating the standards of neurosurgery in the region.

The Revista Mexicana de Neurociencia, published by the ACAD MEXICANA NEUROLOGIA, serves as a pivotal platform for the dissemination of research within the field of neurology and neuroscience. Although it was active from 2008 to 2014 and is no longer covered in Scopus, the journal still holds a significant place in the academic community, addressing critical topics relevant to both clinical and experimental neurology. With an emphasis on advancing knowledge in neuropsychology and public health, this journal targets researchers, professionals, and students alike, fostering an interdisciplinary dialogue that can enhance the understanding of neurological conditions within Mexico and beyond. As it stands, the journal is not open access, which may present challenges for accessibility, yet its affiliation with recognized academic standards underlines its commitment to quality research. This platform once provided insights that can inform practice and stimulate innovative approaches in the management of neurological disorders, underscoring its importance in the evolving landscape of neuroscience.

EXPERIMENTAL NEUROLOGY is a premier academic journal published by Academic Press Inc, Elsevier Science, focusing on advancements in the fields of Developmental Neuroscience and Neurology. With an impressive Impact Factor and ranked in the Q1 quartile of both categories—positioning it among the top-tier journals—this publication has established itself as a vital resource for researchers, clinicians, and students alike. Since its inception in 1959, it has fostered the dissemination of cutting-edge research and innovative approaches to understanding neurological function and related disorders. While EXPERIMENTAL NEUROLOGY currently operates under a subscription access model, its rich archives and ongoing contributions to the field continue to inspire and inform the next generation of neurobiologists. The journal also boasts a high ranking in Scopus, placing fourth in Developmental Neuroscience and twentieth in Neurology, indicating its robust influence and scholarly significance. For those committed to advancing knowledge in these critical areas, EXPERIMENTAL NEUROLOGY is an indispensable platform for inquiry and discovery.

NEUROCHEMISTRY INTERNATIONAL, published by Pergamon-Elsevier Science Ltd, offers a premier platform for researchers and professionals in the realms of cell biology and cellular and molecular neuroscience. Established in 1980 and continuing its passion for advancing the field, this esteemed journal enhances scientific collaboration with a notable 2023 Q2 ranking in both relevant categories, placing it among the top-tier publications in its discipline with a Scopus rank of 23/97 for Cellular and Molecular Neuroscience. With its focus on groundbreaking research, the journal provides a wealth of vital data and insights that drive forward our understanding of neurochemistry and its implications in health and disease. While not an Open Access journal, NEUROCHEMISTRY INTERNATIONAL is integral for professionals, academics, and students aiming to stay at the forefront of neurobiological research innovations, making significant contributions to both academia and clinical applications.

Clinical Neuroradiology, published by SPRINGER HEIDELBERG, is a leading journal in the fields of neurology and radiology, focusing on the intersection of clinical practice and cutting-edge imaging technologies. With an impressive impact factor and categorized within Q2 in Neurology (clinical) and Q1 in Radiology, Nuclear Medicine and Imaging, this journal is positioned at the forefront of scientific discourse, facilitating high-quality research dissemination from its origins in 2000 through to 2024. Situated in Germany, Clinical Neuroradiology provides a platform for researchers, professionals, and students to explore the latest advancements and insights in neuroimaging, ensuring that its readership remains at the vanguard of clinical practice. While it does not offer open access, the journal remains committed to fostering a vibrant academic community dedicated to enhancing patient care through innovative neuroradiological techniques and findings.

Neurotrauma Reports, published by MARY ANN LIEBERT, INC, stands at the forefront of disseminating pivotal research within the evolving field of neuroscience. With an emphasis on both cellular and molecular neuroscience and developmental neuroscience, this open access journal, initiated in 2020, aims to bridge gaps in knowledge concerning neurotrauma, a critical area impacting brain health and recovery. Although currently positioned in the lower quartiles as per the 2023 category rankings, the journal provides invaluable insights that foster academic dialogue and collaboration among researchers, professionals, and students alike. Through its commitment to open access, Neurotrauma Reports ensures that cutting-edge research is accessible to a diverse audience, enhancing the visibility of emerging studies and fostering innovation within the field. Readers can explore this journal to stay updated with the latest findings, methodologies, and reviews that are shaping our understanding of neurotrauma, ultimately contributing to improved treatments and outcomes.

INTERVENTIONAL NEURORADIOLOGY, published by SAGE PUBLICATIONS INC, is a key journal within the interdisciplinary fields of cardiology, neurology, and radiology, focusing on the latest advancements and clinical practices in neuroradiology. With an ISSN of 1591-0199 and an E-ISSN of 2385-2011, this journal has established itself as a vital resource since its inception in 1996, attracting contributions from leading experts worldwide. Currently categorized in the Q2 category for Cardiology and Cardiovascular Medicine and Radiology, and Q3 for Clinical Neurology as of 2023, INTERVENTIONAL NEURORADIOLOGY has gained recognition for its impactful research, reflected in its ranking within the Scopus metrics. Although not an open-access publication, its rigorous peer-reviewed articles provide indispensable knowledge that enhances the practice and understanding of interventional procedures. Researchers, clinicians, and students will find this journal a valuable avenue for insights into the evolving landscape of neuroradiological interventions, ultimately contributing to improved patient outcomes.

Translational Neurodegeneration, an esteemed journal in the field of neuroscience, is published by BMC and has been an open access platform since 2012, delivering high-quality research from its base in the United Kingdom. With an impressive impact factor reflecting its significant contributions, this journal focuses on critical advancements in cellular and molecular neuroscience, cognitive neuroscience, and clinical neurology, boasting a Q1 ranking across all these categories as of 2023. Researchers and professionals benefit from its extensive reach, characterized by exceptional Scopus rankings that place it in the top percentile of its field. The journal serves as a vital resource for academics and healthcare practitioners alike, aiming to bridge the gap between laboratory discoveries and clinical applications, thereby enhancing understanding and treatment of neurodegenerative diseases. With its commitment to open access, Translational Neurodegeneration ensures that its published research is accessible to a global audience, promoting collaboration and knowledge exchange within the scientific community.

Basic and Clinical Neuroscience, published by Iran University of Medical Sciences, is a distinguished open-access journal that has been operational since 2009, providing a platform for the dissemination of significant research in the fields of neuroscience and neurology. With the ISSN 2008-126X and E-ISSN 2228-7442, this journal serves as a vital resource for researchers, clinicians, and students by facilitating access to the latest findings and advancements in cellular and molecular neuroscience as well as clinical neurology. Although currently rated in Q4 for Cellular and Molecular Neuroscience and Q3 for Clinical Neurology as of 2023, it aims to enhance its standing through the publication of high-quality, peer-reviewed research. The journal has achieved a Scopus rank placing it in the 38th percentile for Neurology and the 13th percentile for Neuroscience, indicating a growing recognition of its contributions. With its commitment to open access, Basic and Clinical Neuroscience not only contributes to the scientific community in Iran but also strives to connect researchers worldwide, fostering collaborative efforts in tackling complex neurological challenges.